Join our Community
Support ToI and remove all ads
Learn more
×

Q3 Financial Results

El Al Airlines' Boeing 737s are pictured on the tarmac at Ben Gurion International Airport near Tel Aviv, March 10, 2020. (Jack Guez/ AFP/ File)
November 25, 2020, 11:14 am
El Al posts ‘heavy loss’ in Q3, faces ‘existential risk,’ CEO warns
Israel’s flagship airline posts $147 million loss for the quarter; results come with a ‘going concern’ warning, as second wave of coronavirus pandemic halts flights and recovery
By Shoshanna Solomon
A Bank Leumi in Jerusalem, November 16, 2014. (Yonatan Sindel/Flash90)
From the WebNovember 17, 2020, 11:32 am
Israel’s Bank Leumi third quarter profit dips, loan loss provisions triple
Reuters: The decline in net profit was lower-than-expected, as the surge in loan-loss provisions due to COVID-19 was offset by higher net interest income and lower expenses
Illustrative image of a computer hacker using a smartphone. (stevanovicigor; iStock by Getty Images)
From the WebOctober 22, 2020, 2:53 pm
Check Point Q3 profit, revenue top estimates
Reuters: Cybersecurity firm says 14% rise in quarterly net profit was boosted by a surge in demand for network security products, as more people work remotely amid the pandemic
Bezeq workers installing fiber optic cables. (Courtesy)
From the WebNovember 20, 2018, 10:39 am
Bezeq Israel Telecom Q3 profit falls, moving ahead with restructuring
Reuters: Israel’s largest telecom provider missed analysts forecasts and posted a 27% drop in Q3 profit, hurt by weakness at its mobile phone and Internet services units
A Bank Leumi in Jerusalem, November 16, 2014. (Yonatan Sindel/Flash90)
From the WebNovember 13, 2018, 5:09 pm
Israel’s Bank Leumi Q3 profit beats estimates
Reuters: The Israeli lender earned NIS 936 million ($253 m) in the quarter, up from NIS 820 million a year earlier and beating analysts’ forecasts for a profit of NIS 853 million
Israel Chemicals' Dead Sea Works, the world's fourth largest producer and supplier of potash products. (Yossi Zamir/Flash90)
From the WebNovember 1, 2018, 2:23 pm
Israel Chemicals posts 54% increase in third quarter profit
Globes: The results of the firm that mines minerals from the Dead Sea to make chemicals and potash, were boosted by higher potash prices
A general view of TEVA Pharmaceutical Industries in Jerusalem, Israel, October 11, 2013. (Yonatan Sindel/Flash90)
From the WebNovember 1, 2018, 2:19 pm
Teva Pharm raises 2018 profit outlook after third-quarter tops estimates
Reuters: Israeli drugmaker raises full-year forecast for adjusted earnings per share (EPS) to $2.80-$2.95, from an earlier estimate of $2.55-$2.80
The Jerusalem office of the Israeli drug company Teva Pharmaceuticals (Yonatan Sindel/Flash90)
November 2, 2017, 1:19 pm
Teva cuts forecast for 2017 amid competition to flagship Copaxone drug
The results come as new CEO Kåre Schultz takes the reins of the troubled Israeli drugmaker
By Shoshanna Solomon
Load More
Sign in or Join The Times of Israel Community
Paying ToI Community members are invited to comment on articles
Please use the following structure: example@domain.com
Or Continue with
By joining you agree to the terms and conditions
Register to continue
Or Continue with
Log in to continue
Sign in or Join The Times of Israel Community
Only ToI Community members can comment below articles
Forgot your password? / Send me a login link
Or Continue with
check your email
Check your email
We sent an email to you at .
It has a link that will sign you in.
Join The Times of Israel Community
Commenting is available for paying members of The Times of Israel Community only. Please join our Community to comment and enjoy other Community benefits.
Please use the following structure: example@domain.com
Confirm Mail
Thank you! Now check your email
You are now a member of The Times of Israel Community! We sent you an email with a login link to . Once you're set up, you can start enjoying Community benefits and commenting.
Back to top
Never miss breaking news on Israel
Get notifications to stay updated
You're subscribed
image
Register for free
and continue reading
Registering allows you to manage your newsletters and alerts and helps us improve your experience. It takes just a few seconds.
Already registered? Enter your email to sign in.
Please use the following structure: example@domain.com
Or Continue with
By registering you agree to the terms and conditions. Once registered, you’ll receive our Daily Edition email for free.
Register to continue
Or Continue with
Log in to continue
Sign in or Register
I forgot my password / Send me a sign in link
Or Continue with
check your email
Check your email
We sent an email to you at .
It has a link that will sign you in.